Tradestie Institutional Equity Comparison Engine

DMAC vs ENTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DMAC Overall Edge

DMAC Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DiaMedica Therapeutics Inc. Common Stock (DMAC) driven by superior Growth & Margin, Momentum & Technical while ENTA counters with relative strength in Valuation, Options & Structure. Fundamentally, DMAC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENTA at 44.0x Forward P/E and -90.0% operating margin (-21.6% YoY). In options structure, DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro) against ENTA sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENTA
DMAC N/M vs ENTA 44.0x Fwd P/E
Growth & Margin Winner DMAC
Op Margin 0.0% vs -90.0% ยท YoY +0.0% vs -21.6%
Momentum & Technical Winner DMAC
1Y +54.8% vs -7.9% ยท 52W Pos 55% vs 10%
Options & Structure Winner ENTA
SURGE (14th %ile IV) vs BREAKDOWN (11th %ile IV)
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.39
-4.55% 1D
Market Cap $503.1M
1M Return +10.83%
1Y Return +54.8%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0
ENTA NASDAQ
Enanta Pharmaceuticals, Inc
Pharmaceutical Preparations
$10.79
-1.82% 1D
Market Cap $326.2M
1M Return -2.79%
1Y Return -7.94%
Forward P/E 44.0x
Unified AI Score
46.2 / 100 HOLD
Tech 53.0 Fund 54.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DMAC +54.8% ENTA -7.94% Spread: +62.74 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DMAC Revenue ENTA Revenue DMAC Op. Margin ENTA Op. Margin Margin Edge
FY2018 $0M $210M -1352.2% 42.7% ENTA
FY2019 N/A $210M N/A 17.9% ENTA
FY2020 N/A $120M N/A -34.0% ENTA
FY2021 N/A $100M N/A -112.9% ENTA
FY2022 N/A $90M N/A -143.7% ENTA
FY2023 N/A $80M N/A -173.2% ENTA
FY2024 N/A $70M N/A -179.9% ENTA
FY2025 N/A $70M N/A -130.7% ENTA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DMAC (5) vs ENTA (4)
Institutional Metric DMAC ENTA Criterion Row Winner
Market Capitalization Scale $503.1M $326.2M Larger Scale DMAC
Trailing P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Forward P/E Ratio Valuation N/M 44.0x Lower Multiple ENTA
Revenue Growth (YoY) Growth +0.0% -21.6% Higher Growth DMAC
Operating Margin (TTM) Profitability 0.0% -90.0% Higher Margin DMAC
Net Profit Margin Profitability 0.0% -96.9% Higher Margin DMAC
Return on Equity (ROE) Capital Efficiency -114.6% -70.1% Higher ROE ENTA
52-Week Range Position Momentum 55% ($5โ€“$11) 10% ($10โ€“$17) Stronger Trend DMAC
Beta / 30D Volatility Risk Regime 1.72ฮฒ ยท 97% Vol 0.89ฮฒ ยท 58% Vol Lower Realized Risk ENTA
Unified Institutional Score Composite Signal 46.3 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DMAC vs ENTA Buy Guide
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENTA BREAKDOWN
95d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live ENTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DMAC nor ENTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.